While the earliest oncogenic MDM4 activities identified were demonstrated to be wt p53 dependent, recent findings indicate that its repertoire is far more extensive with ramifications for cancers lacking functional p53 as we discuss in the following section. This evidence concerns the gene TP53 and cancer.